Innate Pharma H1 EPS $(0.28) Up From $(0.34) YoY, Sales $5.51M Down From $13.35M YoY
Benzinga Newsdesk 1 year ago
EarningsNews
Innate Pharma (NASDAQ:IPHA) reported quarterly losses of $(0.28) per share. This is a 16.76 percent increase over losses of $(0.34) per share from the same period last year. The company reported $5.51 million in sales
Innate Pharma (NASDAQ:IPHA) reported quarterly losses of $(0.28) per share. This is a 16.76 percent increase over losses of $(0.34) per share from the same period last year. The company reported $5.51 million in sales this quarter. This is a 58.72 percent decrease over sales of $13.35 million the same period last year.